GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **26 - 50** of **4050** in total

« First

‹ Prev

1

2

3

4

5

6

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgM	Patient 3	11	mild	G99603GB	10947
IgM	Patient 3	4	mild	G99603GB	10882
IgA	Patient 4	12	mild	G99603GB	398
IgG	Patient 4	12	mild	G99603GB	646
IgM	Patient 4	12	mild	G99603GB	219
IgA	Patient 1	10	moderate	G98240FC	383
IgA	Patient 1	22	moderate	G98240FC	422
IgA	Patient 1	6	moderate	G98240FC	344
IgG	Patient 1	10	moderate	G98240FC	39
IgG	Patient 1	22	moderate	G98240FC	58
IgM	Patient 1	10	moderate	G98240FC	72
IgM	Patient 1	22	moderate	G98240FC	263
IgA	Patient 2	15	mild	G98240FC	424
IgA	Patient 2	24	mild	G98240FC	441
IgG	Patient 2	15	mild	G98240FC	344
IgG	Patient 2	24	mild	G98240FC	262
IgM	Patient 2	15	mild	G98240FC	397
IgG	Patient 1	6	moderate	G98240FC	33
IgM	Patient 1	6	moderate	G98240FC	59
IgA	Patient 2	3	mild	G98240FC	441
IgG	Patient 2	3	mild	G98240FC	430
IgM	Patient 2	24	mild	G98240FC	364
IgM	Patient 2	3	mild	G98240FC	446
IgA	Patient 3	-180	mild	G98240FC	287
IgA	Patient 3	11	mild	G98240FC	388